MiR-30 Family Potentially Targeting PI3K-SIAH2 Predicted Interaction Network Represents a Novel Putative Theranostic Panel in Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

MiR-30 Family Potentially Targeting PI3K-SIAH2 Predicted Interaction Network Represents a Novel Putative Theranostic Panel in Non-small Cell Lung Cancer

Published:2017-02-02 Issue: Volume:8 Page:
ISSN:1664-8021
Container-title:Frontiers in Genetics
language:
Short-container-title:Front. Genet.

Author:

Chan Lawrence W. C.,Wang Fengfeng,Meng Fei,Wang Lili,Wong Sze Chuen Cesar,Au Joseph S. K.,Yang Sijun,Cho William C. S.

Funder

Food and Health Bureau

Publisher

Frontiers Media SA

Subject

Genetics (clinical),Genetics,Molecular Medicine

Reference29 articles.

1. Endogenous miRNA and target concentrations determine susceptibility to potential ceRNA competition.;Bosson;Mol. Cell,2014

2. Molecular mechanisms of resistance to therapies targeting the epidermal growth factor receptor.;Camp;Clin. Cancer Res.,2005

3. Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling.;Emerling;Mol. Cell Biol.,2005

4. Racial and sex differences in presentation and outcomes of small cell lung cancer in the United States: 1973 to 2010.;Eskandar;Chest,2015

5. STRING v9.1: protein-protein interaction networks, with increased coverage and integration.;Franceschini;Nucleic Acids Res.,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the role of microRNAs associated with the PI3K/AKT signaling pathway in lung cancer;Frontiers in Oncology;2023-12-19

2. Prospects of microRNAs as therapeutic biomarkers in non-small cell lung cancer;Medical Oncology;2023-11-03

3. Role of Non-Coding RNAs in Lung Cancer;Recent Advances in Noncoding RNAs;2022-11-02

4. Relationship between the microRNAs and PI3K/AKT/mTOR axis: Focus on non-small cell lung cancer;Pathology - Research and Practice;2022-11

5. Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progression;eLife;2022-08-01